Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1.

Genetics in medicine : official journal of the American College of Medical Genetics（2023）

引用 1|浏览13

暂无评分

摘要

These findings confirm the long-term efficacy of eliglustat on skeletal complications of Gaucher disease in treatment-naïve and ERT-switch patients.

查看译文

关键词

Acid β-glucosidase deficiency,Eliglustat,Gaucher disease type 1,Skeletal manifestations,Substrate reduction therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要